Esomeprazole magnesium trihydrate
| | 217087-09-7 Basic information More.. |
| Product Name: | Esomeprazole magnesium trihydrate | | Synonyms: | ESOMEPRAZOLE MAGNESIUM TRIHYDRATE;bis(5-methoxy-2-[(s)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzylimidazole-1-yl) magnesium trihydrate;(T-4)-Bis[5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolato]magnesium;Nexium;ESOPMEPRAZOLE MG TRIHYDRATE;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide;5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide | | CAS: | 217087-09-7 | | MF: | C34H38MgN6O7S2 | | MW: | 731.14 | | EINECS: | 669-839-3 | | Mol File: | 217087-09-7.mol |  |
Use
esomeprazole magnesium trihydrate for the healing of peptic ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy.
Zollinger-Ellison syndrome
Peptic ulcer, site unspecified
Duodenal ulcer
Gastric ulcer
Gastro-oesophageal reflux disease
Esomeprazole belongs to the family of medications known as proton pump inhibitors (PPIs). Esomeprazole is registered by the Therapeutic Goods Administration (TGA) for the following indications:
Gastro-Oesophageal Reflux Disease (GORD):
treatment of erosive reflux oesophagitis;
long-term management of patients with healed oesophagitis to prevent relapse;
symptomatic treatment of gastro-oesophageal reflux disease (GORD).
In combination with appropriate antibiotics for:
healing of duodenal ulcer associated with Helicobacter pylori;
eradication of Helicobacter pylori in patients with active or healed peptic ulcer.
Short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug (NSAID) (non-selective and COX-2 selective) therapy.
Healing of gastric ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy.
Prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy in patients at risk.
|
|
217087-09-7
Recommend Suppliers |
|
| Tag:
217087-09-7
|